WallStreetZenWallStreetZen

NASDAQ: MDXH
Mdxhealth Sa Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MDXH

Based on 3 analysts offering 12 month price targets for Mdxhealth Sa

Min Forecast
$1.50+78.78%
Avg Forecast
$3.50+317.16%
Max Forecast
$5.00+495.95%

Should I buy or sell MDXH stock?

Based on 3 analysts offering ratings for Mdxhealth Sa.

Strong Buy
Strong Buy
3 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although MDXH's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates MDXH as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their MDXH stock forecasts and price targets.

MDXH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-05-14
lockedlocked$00.00+00.00%2026-05-14
lockedlocked$00.00+00.00%2026-05-14

1 of 1

Forecast return on equity

Is MDXH forecast to generate an efficient return?

Company
N/A
Industry
-84.08%
Market
174.48%

Forecast return on assets

Is MDXH forecast to generate an efficient return on assets?

Company
N/A
Industry
15.01%

MDXH earnings per share forecast

What is MDXH's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
-$0.49
Avg 2 year Forecast
-$0.26
Avg 3 year Forecast
$0.07

MDXH revenue forecast

What is MDXH's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$127.8M+18.42%
Avg 2 year Forecast
$147.8M+36.96%
Avg 3 year Forecast
$143.3M+32.85%
MDXH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MDXH revenue growth forecast

How is MDXH forecast to perform vs Diagnostics & Research companies and vs the US market?

Company
12.06%
Industry
7.96%
Market
14.15%
MDXH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MDXH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MDXH vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
MDXH$0.84$3.50+317.16%Strong Buy
ISPC$3.67N/AN/A
BNBX$0.41N/AN/A
ADVB$4.42N/AN/A
NDRA$5.59$30.00+436.67%Buy
View Top Diagnostic & Research Stocks

Mdxhealth Sa Stock Forecast FAQ

Is Mdxhealth Sa Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: MDXH) stock is to Strong Buy MDXH stock.

Out of 3 analysts, 3 (100%) are recommending MDXH as a Strong Buy, 0 (0%) are recommending MDXH as a Buy, 0 (0%) are recommending MDXH as a Hold, 0 (0%) are recommending MDXH as a Sell, and 0 (0%) are recommending MDXH as a Strong Sell.

If you're new to stock investing, here's how to buy Mdxhealth Sa stock.

What is MDXH's earnings growth forecast for 2026-2028?

(NASDAQ: MDXH) Mdxhealth Sa's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 18.33%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.32%.

Mdxhealth Sa's earnings in 2026 is -$33,519,000.On average, 8 Wall Street analysts forecast MDXH's earnings for 2026 to be -$25,322,708, with the lowest MDXH earnings forecast at -$34,229,316, and the highest MDXH earnings forecast at -$15,640,496. On average, 8 Wall Street analysts forecast MDXH's earnings for 2027 to be -$13,519,142, with the lowest MDXH earnings forecast at -$22,651,753, and the highest MDXH earnings forecast at -$4,314,620.

In 2028, MDXH is forecast to generate $3,667,427 in earnings, with the lowest earnings forecast at $3,523,606 and the highest earnings forecast at $3,775,292.

What is MDXH's revenue growth forecast for 2026-2028?

(NASDAQ: MDXH) Mdxhealth Sa's forecast annual revenue growth rate of 12.06% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.96%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.15%.

Mdxhealth Sa's revenue in 2026 is $107,875,000.On average, 8 Wall Street analysts forecast MDXH's revenue for 2026 to be $6,561,817,430, with the lowest MDXH revenue forecast at $5,557,127,419, and the highest MDXH revenue forecast at $7,550,584,440. On average, 8 Wall Street analysts forecast MDXH's revenue for 2027 to be $7,589,107,830, with the lowest MDXH revenue forecast at $6,121,109,848, and the highest MDXH revenue forecast at $8,898,903,090.

In 2028, MDXH is forecast to generate $7,361,049,361 in revenue, with the lowest revenue forecast at $7,072,380,759 and the highest revenue forecast at $7,577,807,636.

What is MDXH's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: MDXH) forecast ROA is N/A, which is lower than the forecast US Diagnostics & Research industry average of 15.01%.

What is MDXH's Price Target?

According to 3 Wall Street analysts that have issued a 1 year MDXH price target, the average MDXH price target is $3.50, with the highest MDXH stock price forecast at $5.00 and the lowest MDXH stock price forecast at $1.50.

On average, Wall Street analysts predict that Mdxhealth Sa's share price could reach $3.50 by May 14, 2027. The average Mdxhealth Sa stock price prediction forecasts a potential upside of 317.16% from the current MDXH share price of $0.84.

What is MDXH's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: MDXH) Mdxhealth Sa's current Earnings Per Share (EPS) is -$6.70. On average, analysts forecast that MDXH's EPS will be -$0.49 for 2026, with the lowest EPS forecast at -$0.67, and the highest EPS forecast at -$0.30. On average, analysts forecast that MDXH's EPS will be -$0.26 for 2027, with the lowest EPS forecast at -$0.44, and the highest EPS forecast at -$0.08. In 2028, MDXH's EPS is forecast to hit $0.07 (min: $0.07, max: $0.07).

What is MDXH's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: MDXH) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.